Lentivirus Services

Our Services

At PackGene, we specialize in providing tailored Lentivirus services to meet your research needs. Whether you’re conducting in vitro discovery work, in vivo experiments, or pre-clinical studies, we offer Lentivirus solutions in a wide range of quantities and qualities. Our one-stop solution covers everything from vector design and virus packaging to thorough analysis and testing.

Explore our Lentivirus Packaging service for reliable and scalable solutions tailored to your needs, with prompt delivery times. Our accurate titer measurements with post-transduction qPCR eliminate any concerns of overestimation. Additionally, our enhanced safety measures, such as the “self-inactivating” 3rd-generation system, increase biosafety.

Take advantage of our Gene to Lentivirus service, where we guide you through the process of transforming genes into lentiviruses, streamlining your research endeavors. Our comprehensive services begin with assisting you from the initial stages of designing and constructing lentivirus plasmids to the seamless delivery of the virus.

We understand the importance of quality control, which is why we conduct additional QC tests to ensure the reliability and efficiency of our lentiviral products. Alongside post-transduction titer measurements, we also offer p24 ELISA, Mycoplasma tests, Bioburden tests, Endotoxin tests, and many more.

Experience the difference with PackGene – your trusted partner for Lentivirus solutions. Contact us today to learn more and discuss how we can support your research goals.

Gene to Lentivirus Service

Lentivirus Packaging Service

2. Contact us (page)

Full Name *

Email *

Phone (Optional)

Institute / Company *

Country *

State / Province

State / Province (Optional)

Post Code (Optional)

What services are you inquiring about? What services are you inquiring about?

Message *

Subscribe for the latest news, press, and updates from PackGene.

Resources

FAQ

What are the differences between in vitro grade and in vivo grade lentivirus?

The purification processes for in vitro grade and in vivo grade lentivirus are different. Both grades undergo sterile filtration before release, but in vivo grade purification involves additional stringent steps such as ultracentrifugation and ultrafiltration. In vitro grade lentivirus is intended for cell culture experiments, while preclinical-grade lentivirus can be used for both cell culture and in vivo animal studies.

How much plasmid do I need to provide for lentivirus packaging?

You only need to provide 1-4 µg of plasmid. We will handle the plasmid preparation necessary for lentivirus packaging. You don’t need to purchase an additional plasmid prep service unless you wish to receive more plasmid from us. Please note, the timeline in our quote already includes the plasmid preparation.

What QC tests do you conduct on your lentivirus?

Lentivirus quality control (QC) encompasses various tests to ensure the integrity and safety of lentiviral vectors for research and therapeutic applications.Our release QC testing primarily focuses on post-transduction titer, which provides a true functional titer(infectious titer) to prevent overestimation.

Post-transduction qPCR involves infecting cells with lentivirus followed by quantifying viral titers using quantitative PCR (qPCR), providing essential information about lentiviral transduction efficiency.

Transduction tests are performed by infecting cells with lentivirus and diluting them to count fluorescent cells. Bright field and fluorescent microscopy images are then analyzed to evaluate transduction efficiency.

Additional QC tests include p24 ELISA to measure the core capsid protein of HIV for accurate lentivirus titration, PCR-based mycoplasma testing to ensure absence of contamination, bioburden testing to quantify live microorganisms, and endotoxin testing using the Limulus amebocyte lysate (LAL) assay to confirm absence of endotoxin contamination.

These comprehensive QC tests ensure that lentiviral vectors are of high quality, free from contaminants, and suitable for downstream research and therapeutic applications.

What are the benefits of using the 3rd generation lentivirus system?

The 3rd generation lentivirus packaging system offers several benefits. It is inherently safer as it does not replicate and self-inactivate, ensuring enhanced biosafety. This system utilizes four plasmids, each carrying different HIV genes, including the removal of tat, which is advantageous for optimizing safety profiles. Additionally, it features a partially removed 5′ LTR followed by a strong promoter such as CMV, RSV, EF1, or U6 for RNA, enhancing transduction efficiency and reducing the risk of insertional mutagenesis. Furthermore, the removal of U3 renders the lentivirus self-inactivating (SIN), minimizing the risk of unintended integration and enhancing the safety profile of lentiviral vectors for gene delivery applications.

How should lentivirus be stored, and what is their shelf life?

Lentivirus can be stored for up to 6 months at -80°C, although its titer may decrease after this period. To maintain optimal titer, we recommend avoiding freeze-thaw cycles and aliquoting the lentivirus into smaller portions upon the first thaw. We also offer aliquoting services. The first 10 vials aliquoting is complimentary, with a charge of $5 per additional vial.

What is the genome capacity between the 5' LTR and 3' LTR of lentivirus?

The lentivirus genome size between LTRs is about 9.3kb. However, to ensure optimal yield during lentivirus production, we recommend keeping the lentivirus genome size between LTRs below 6.5kb. If the genome size exceeds this limit, we cannot guarantee the desired yield. Additionally, if the initial yield does not meet expectations, we will initiate a second batch production to ensure accuracy.

How is the lentivirus titer determined?

In contrast to the common practice among most vendors, who typically measure lentivirus titer directly using methods such as qPCR or p24 ELISA. The Traditional p24 ELISA kit is the most commonly published method for measuring lentiviral titer. The method is suitable for tittering native or purified recombinant virus. However, in crude (unpurified) lentiviral supernatant, significant concentrations of overexpressed p24 protein may be present that are not assembled into viral particles. This causes an extreme overestimation of lentiviral titer.

We employ a different approach. Our titer measurement focuses on the post-transduction titer determined by qPCR, which helps to eliminate any concerns regarding overestimation, providing infectious titers that are significantly higher (100-1000 times) than the physical titer measured by p24, ensuring greater accuracy and consistency for experimental applications.

Additionally, if the lentivirus carries a fluorescent protein, we can further validate the post-transduction titer by examining bright-field and fluorescent microscopy images obtained from serial dilutions of the virus.

What is the difference between physical titer and infectious titer?

Viral titers are typically reported in two forms: functional titer(infectious titer), expressed as transduction units (TU/mL), and physical titer, measured in viral particles (VP/mL). The physical titer indicates the total amount of virus present, often quantified by assessing levels of viral proteins like p24 or viral nucleic acids. In contrast, the functional titer(infectious titer) reflects the virus’s ability to infect cells and is usually 100 to 1000 times lower than the physical titer. Although direct measurement of functional titer(infectious titer) is more accurate for calculating the multiplicity of infection (MOI), it is often more labor-intensive. At PackGene, lentivirus scale is based on post-transduction titer, providing infectious titers that are significantly higher than the physical titer measured by p24, ensuring greater accuracy for experimental applications.

Do you offer assistance design lentivirus plasmid?

Yes. We offer piVector Designer, an online-tool to help you design the lentivirus plasmid. The plamid backbones of various application we provided in piVector Designer is experimentally validated by us, and we provide a vast library of gene elements including promoter, reporter/marker, regulatory elements and polyA. Also, our Ph.D. level techincal support team will evaluate